1. Home
  2. BMI vs GPCR Comparison

BMI vs GPCR Comparison

Compare BMI & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BMI

Badger Meter Inc.

HOLD

Current Price

$160.54

Market Cap

4.3B

Sector

Industrials

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$54.50

Market Cap

3.9B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMI
GPCR
Founded
1905
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
3.9B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
BMI
GPCR
Price
$160.54
$54.50
Analyst Decision
Buy
Strong Buy
Analyst Count
9
11
Target Price
$188.57
$103.36
AVG Volume (30 Days)
286.3K
1.1M
Earning Date
04-17-2026
05-07-2026
Dividend Yield
0.99%
N/A
EPS Growth
13.24
N/A
EPS
4.79
N/A
Revenue
N/A
N/A
Revenue This Year
$6.50
N/A
Revenue Next Year
$6.74
N/A
P/E Ratio
$33.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$139.14
$15.80
52 Week High
$256.08
$94.90

Technical Indicators

Market Signals
Indicator
BMI
GPCR
Relative Strength Index (RSI) 61.40 49.04
Support Level $142.68 $17.89
Resistance Level $163.16 $61.20
Average True Range (ATR) 5.03 3.45
MACD 1.07 1.45
Stochastic Oscillator 97.13 78.11

Price Performance

Historical Comparison
BMI
GPCR

About BMI Badger Meter Inc.

Badger Meter is a provider of water management solutions. The company's solutions encompass measurement and control hardware, connectivity and communication, data visualization and software. Badger Meter has globalised operations, with the vast majority of revenue derived from the USA. The company is an innovator in flow measurement, water quality and control products, serving water utilities, municipalities and commercial and industrial customers world-wide.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: